Bayer has acquired German biotech start-up Targenomix. The spin-off of the Max Planck Institute for Molecular Plant Physiology (MPI MPP) makes use of novel methods biology and computational life science instruments to establish new modes of motion for crop safety compounds.
“Targenomix’ strategy has confirmed to be very profitable,” mentioned Dr. Robert Reiter, Head of R&D at Bayer’s Crop Science Division. “By utilizing a singular and holistic methods biology strategy and leveraging experience constructing on a powerful scientific basis stemming from the MPI MPP, Targenomix has delivered quite a few novel targets and modes of motion for small molecules in weed management. Their progressive instruments to establish and choose protected and sustainable compounds complement our design-based technique in crop safety discovery and can speed up the event of recent merchandise that farmers want to fulfill future challenges of agriculture.”
By additional integrating Targenomix’ methods biology strategy into Bayer’s established R&D pipeline, Bayer is driving the event of recent applied sciences in the direction of protected and efficient merchandise that farmers want.
“Combining Bayer’s capabilities and confirmed crop safety pipeline with Targenomix’ versatile start-up mindset, deep multi-omics know-how, and methods biology experience will permit us collectively to proceed to ship novel modes of motion,” mentioned Dr. Sebastian Klie, CEO of Targenomix. “This new section of our complementary relationship will speed up the invention of the subsequent era of sustainable and protected molecules.”
Bayer and Targenomix have been working collectively efficiently since 2014, with the invention and growth of the business’s first new post-emergence herbicide mode of motion (MOA) for broadacre weed management in 30 years supported by the collaboration. This molecule has demonstrated efficient management of key resistant grasses in analysis and is predicted to be commercialized in the direction of the tip of this decade.
“I’m very completely happy in regards to the integration of Targenomix into the Bayer household which secures a long-term future for Targenomix and its staff,” mentioned Prof. Dr. Lothar Willmitzer, director emeritus of the MPI MPP and founding father of Targenomix. “Targenomix’ distinctive experience in methods and computational biology will considerably strengthen and broaden the capabilities of Bayer within the space of crop safety and past, and maintaining Targenomix at arm’s size ensures that the spirit of Targenomix is maintained, a key requisite for its additional success. Bayer’s resolution to accumulate Targenomix is one other instance of the excessive worldwide recognition Max-Planck-Institutes get pleasure from for his or her science.”
For extra info: